# Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients

> **NCT01377467** · PHASE3 · COMPLETED · sponsor: **Rudolf Wuethrich** · enrollment: 90 (actual)

## Conditions studied

- Osteoporosis
- Chronic Kidney Disease

## Interventions

- **DRUG:** Denosumab (Prolia)

## Key facts

- **NCT ID:** NCT01377467
- **Lead sponsor:** Rudolf Wuethrich
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2015-05
- **Final completion:** 2015-10
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2016-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01377467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01377467, "Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01377467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*